WESTADONE Drug Patent Profile
✉ Email this page to a colleague
When do Westadone patents expire, and what generic alternatives are available?
Westadone is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in WESTADONE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Westadone
A generic version of WESTADONE was approved as methadone hydrochloride by ROXANE on March 8th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WESTADONE?
- What are the global sales for WESTADONE?
- What is Average Wholesale Price for WESTADONE?
Summary for WESTADONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Patent Applications: | 3,137 |
| DailyMed Link: | WESTADONE at DailyMed |
US Patents and Regulatory Information for WESTADONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | WESTADONE | methadone hydrochloride | TABLET, DISPERSIBLE;ORAL | 017108-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | WESTADONE | methadone hydrochloride | TABLET, EFFERVESCENT;ORAL | 017108-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | WESTADONE | methadone hydrochloride | TABLET, EFFERVESCENT;ORAL | 017108-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | WESTADONE | methadone hydrochloride | TABLET, EFFERVESCENT;ORAL | 017108-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
